PDSB icon

PDS Biotechnology
PDSB

Overview Fund Activity

47 hedge funds and large institutions have $9.79M invested in PDS Biotechnology in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 12 closing their positions.

Holders
47
Holders Change
-4
Holders Change %
-7.84%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
11
Reduced
12
Closed
12
Calls
$315K
Puts
$2K
Net Calls
+$313K
Net Calls Change
+$169K

Top Buyers

1
AC
1
Armistice Capital
New York
$5.26M
2
UBS Group
2
UBS Group
Switzerland
$299K
3
William Blair & Company
3
William Blair & Company
Illinois
$306K
4
IGGA
4
Iron Gate Global Advisors
Utah
$89.3K
5
VPIM
5
Vanguard Personalized Indexing Management
California
$33.9K

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$30.6K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$0
4
Two Sigma Investments
4
Two Sigma Investments
New York
$0
5
Millennium Management
5
Millennium Management
New York
$60.2K
Name Holding Trade Value Shares
Change 		Shares
Change %
Vontobel Holding
51
Vontobel Holding
Switzerland
– -$65.2K -40,000 Closed
Marshall Wace
52
Marshall Wace
United Kingdom
– -$63.6K -39,024 Closed
Jane Street
53
Jane Street
New York
– -$58.1K -35,644 Closed
XT
54
XTX Topco
Cayman Islands
– -$40K -24,535 Closed
SPA
55
Sherbrooke Park Advisers
New York
– -$22.9K -14,026 Closed
EWA
56
EverSource Wealth Advisors
Alabama
– -$703 -431 Closed
RS
57
R Squared
Hong Kong
– -$489 -300 Closed
Citigroup
58
Citigroup
New York
– -$33 -20 Closed
1 2
3